Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05926024 · ClinicalTrials.gov registry record
Long-Term Follow-Up in Women With Early Breast Cancer Three Years of More Post Primary Treatment
A clinical trial of Breast Cancer, sponsored by UNC Lineberger Comprehensive Cancer Center.
- Active
- Registry status
- 253
- Enrollment target
- 1
- Study location
NCT05926024: Active study of Breast Cancer, sponsored by UNC Lineberger Comprehensive Cancer Center.
NCT05926024 is a study of Breast Cancer that is active but no longer recruiting, run by UNC Lineberger Comprehensive Cancer Center. The registered enrollment target is 253 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05926024, a study of Breast Cancer, is active but no longer recruiting, sponsored by UNC Lineberger Comprehensive Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- 253 participants
- Enrollment target
- 1
- Study location
Study Summary
This study evaluates whether there are pre-treatment factors such as patient characteristics, specific breast cancer type, specific treatments, toxicities, or adverse events during treatment that may impact the quality of life and function, 3 years or more after the treatment, in cancer-free subjects. There will be 2 groups. Cohort A: Women who participated in previous studies namely NCT02167932, NCT02328313, and NCT03761706, will be re-contacted and consent for this study activities. Cohort B: Women with breast cancer, who did not receive chemotherapy, will be consented to be included in the study, and their electronic medical data will be used. Furthermore, the long-term effects of treatment and a biomarker of aging cyclin-dependent kinase inhibitor 2A (CDKN2A,p16INK4a) and relation will be assessed.
Conditions Studied
Interventions
- BEHAVIORAL Exercise Recall Patient Reported Outcomes
- BEHAVIORAL Health Behavior Questionnaire (HBQ)30 Patient Reported Outcomes
- BEHAVIORAL Functional Assessment of Cancer Therapy-General (FACT-G) Patient Reported Outcomes
- BEHAVIORAL Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F) Patient Reported Outcomes
- BEHAVIORAL Patient Reported Outcomes PROMIS Cognitive Function (Short Form 8a)
Study Locations (1)
North Carolina
- University of North Carolina - Chapel Hill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 253 participants |
| Start Date | 2023-01-06 |
| Est. Completion | 2028-01-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05926024
The ClinicalTrials.gov registry entry for NCT05926024 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 253 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (91% lower). The listed sponsor is UNC Lineberger Comprehensive Cancer Center, which has 366 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 5 interventions - of which Exercise Recall Patient Reported Outcomes is the first listed.
NCT05926024 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT05926024 about?
NCT05926024 is a clinical study titled "Long-Term Follow-Up in Women With Early Breast Cancer Three Years of More Post Primary Treatment". This study evaluates whether there are pre-treatment factors such as patient characteristics, specific breast cancer type, specific treatments, toxicities, or adverse events during treatment that may impact the quality of life and function, 3 years or more after the treatment, in cancer-free subject...
What is the current status of trial NCT05926024?
This trial is currently active not recruiting. The enrollment target is 253 participants. The study started on 2023-01-06. Estimated completion is 2028-01-31.
What conditions does trial NCT05926024 study?
This clinical trial studies the following conditions: Breast Cancer.
What interventions are being tested in trial NCT05926024?
The interventions under investigation include: Exercise Recall Patient Reported Outcomes (BEHAVIORAL), Health Behavior Questionnaire (HBQ)30 Patient Reported Outcomes (BEHAVIORAL), Functional Assessment of Cancer Therapy-General (FACT-G) Patient Reported Outcomes (BEHAVIORAL), Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F) Patient Reported Outcomes (BEHAVIORAL), Patient Reported Outcomes PROMIS Cognitive Function (Short Form 8a) (BEHAVIORAL).
Who is sponsoring clinical trial NCT05926024?
This trial is sponsored by UNC Lineberger Comprehensive Cancer Center, which has 366 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05926024 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Surviving Daily Life
RECRUITING
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
UNC Pleural Fluid Registry
RECRUITING
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.